Rita Morigi
University of Bologna
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rita Morigi.
European Journal of Medicinal Chemistry | 2001
Aldo Andreani; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi
A number of selected imidazo[2,1-b]thiazoles entered the screening at the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) and one of these compounds, 2-chloro-6-phenylimidazo[2,1-b]thiazole, showed antitubercular activity. On this basis we planned the synthesis of new analogues bearing a substituted ring at the 6 position. For one compound only (2-chloro-6-p-chlorophenylimidazo[2,1-b]thiazole) the 5-nitroso derivative was also prepared. The antitubercular activity of these compounds was compared with the known analogues lacking the chlorine at the 2 position. 5-Nitroso-6-p-chlorophenylimidazo[2,1-b]thiazole showed potent antitubercular activity.
European Journal of Medicinal Chemistry | 1997
Aldo Andreani; Alessandra Locatelli; Alberto Leoni; Mirella Rambaldi; Rita Morigi; Rosaria Bossa; M Chiericozzi; Alessandra Fraccari; I. Galatulas
Summary A compound endowed with coanthracyclinic activity should potentiate the antitumor activity of anthracyclines while counteracting their cardiodepressant effect. We now report the synthesis and configuration of a series of substituted 3-(5-imidazo[2,1- b ]thiazolylmethylene)-2-indolinones which were tested for both cardiotonic and cytotoxic activity. Several compounds were potent cytotoxic agents and two of them (in particular 3-[6-(2,5-dimethoxyphenyl)-5-imidazo[2,1- b ]thiazolylmethylene]-2 -indolinone, which showed even cardiotonic activity, are potential coanthracyclinic agents.
European Journal of Medicinal Chemistry | 2000
Aldo Andreani; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Claudio Pietra; Gino Villetti
Acetylcholine (Ach) enhancement, useful in the treatment of Alzheimers disease (AD), may be obtained by means of ion channel modulators such as 4-aminopyridine (4-AP). 4-AP is also the central ring of tacrine, the first drug approved for the treatment of AD. The synthesis and pharmacological activity of three 4-AP derivatives, prepared with the aim of improving their antiamnesic activity, is here described. In two of these compounds 4-AP is connected to 4-aminobutyric acid (GABA), whereas in the third it is connected to 2-indolinone, i.e., the skeleton of linopirdine, another Ach enhancing agent. The new compounds showed potent antiamnesic activity in comparison with piracetam.
European Journal of Medicinal Chemistry | 1999
Aldo Andreani; Mirella Rambaldi; Alberto Leoni; Rita Morigi; Alessandra Locatelli; Gianluca Giorgi; Giorgio Lenaz; Anna Ghelli; Mauro Degli Esposti
Starting from the potent inhibitory effect of the previously described 2-methyl-6-(2-thienyl)imidazo[2,1-b]thiazole on mitochondrial complex I, we prepared a series of derivatives in order to study the effect of a different substitution at the positions 2, 5 and 6. The replacement of the thienyl group at position 6 with a phenyl group does not modify the biological behaviour of the lead compound, whereas the shift of the methyl group from position 2 to position 5 yields a compound devoid of inhibitory effects. In both the 6-thienyl and 6-phenyl series, the lengthening of the chain at position 2 has provided useful information to outline the structural determinants of the ubiquinone antagonist action in imidazothiazole derivatives.
European Journal of Medicinal Chemistry | 1998
Aldo Andreani; Alessandra Locatelli; Alberto Leoni; Rita Morigi; M Chiericozzi; Alessandra Fraccari; I. Galatulas; Gaetano Salvatore
The synthesis of pyridylmethylene lactams and indolylmethylene-2-indolinones is reported. These compounds were tested for their cytotoxic and positive inotropic activity. The presence of both the effects (coanthracyclinic activity) was confirmed in some of the indolylmethylene-2-indolinones.
Anti-cancer Drug Design | 2001
Aldo Andreani; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Gianluca Giorgi; Laura Salvini; Garaliene
Drug Research | 2011
Aldo Andreani; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Wolfgang Simon; Joerg Senn‐Bilfinger
Anti-cancer Drug Design | 2000
Aldo Andreani; Andrea Cavalli; Massimiliano Granaiola; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Maurizio Recanatini; Matthieu Garnier; Laurent Meijer
Drug Research | 1998
Aldo Andreani; Alessandra Locatelli; Rita Morigi; Alberto Leoni; Rosaria Bossa; M Chiericozzi; I. Galatulas
Collection of Czechoslovak Chemical Communications | 1999
Aldo Andreani; Alberto Leoni; Alessandra Locatelli; Rita Morigi; Mirella Rambaldi; Jean-Claude Gehret; Serena Traniello; Alessio Cariani; Susanna Spisani